Cargando…
A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers
Neuroendocrine prostate cancer (NEPC) represents a highly aggressive form of prostate tumors. NEPC results from trans-differentiated castration-resistant prostate cancer (CRPC) with increasing evidence indicating that the incidence of NEPC often results from the adaptive response to androgen depriva...
Autores principales: | Elhasasna, Hussain, Khan, Raymond, Bhanumathy, Kalpana K., Vizeacoumar, Frederick S., Walke, Prachi, Bautista, Maricris, Dahiya, Dinesh K., Maranda, Vincent, Patel, Hardikkumar, Balagopal, Amrutha, Alli, Nezeka, Krishnan, Anand, Freywald, Andrew, Vizeacoumar, Franco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317991/ https://www.ncbi.nlm.nih.gov/pubmed/35883689 http://dx.doi.org/10.3390/cells11142246 |
Ejemplares similares
-
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
por: K. Bhanumathy, Kalpana, et al.
Publicado: (2021) -
Sympathetic signaling facilitates progression of neuroendocrine prostate cancer
por: Dwivedi, Shubham, et al.
Publicado: (2021) -
Identification of novel genes involved in apoptosis of HIV-infected macrophages using unbiased genome-wide screening
por: Dong, Simon X. M., et al.
Publicado: (2021) -
Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
por: Arna, Ananna Bhadra, et al.
Publicado: (2023) -
An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer
por: Auslander, Noam, et al.
Publicado: (2017)